fda approval for semaglutide 🎉Exciting news that is now approved MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Novo Nordisk's Ozempic® pill, the

The proven ability of GLP-1s to lower HbA1c with a low risk of hypoglycemia has now skyrocketed their adoption

Aging reduces NAD+ synthesis pathways while increasing consumption by enzymes like CD38 and PARPs, activated by inflammation and damage.[13][15] CD38, an immune-related enzyme, ramps up with age, breaking down NAD+ precursors

This is what Weight Watchers delivers, said Weight Watchers CEO Tara Comonte

Programs may include medical weight loss, semaglutide treatment, tirzepatide treatment, peptide therapy, and personalized wellness consultations

GLP-1 drugs and their labeling and regulatory history relevant to NAION